Categories
Search

Archive for July, 2009

Two glasses of red a day may prevent Alzheimer’s

Thursday, July 30th, 2009

According to a fashionable office those two of glasses red wine each day may be enjoyable but might also help debar Alzheimer’s disease.

It seems that when mice with an Alzheimer’s-like disease were given the equivalent of a couple of glasses of red wine a day, it slowed down their memory loss and brain cell death.


Compared to mice that received ethanol or water, the mice that were given Cabernet Sauvignon experienced significantly reduced Alzheimer’s disease-type brain deterioration of memory function.


The researchers, from Mount Sinai School of Medicine in New York City, found Cabernet Sauvignon’s benefits were due to its ability to prevent the generation of proteins that cause plaque build-up in the brain, which is the main cause of Alzheimer’s disease.


The researchers calculated the animals’ wine intake to match the US Department of Agriculture’s definition of moderate wine consumption, a single 5-ounce glass daily for women and two glasses for men.


Dr. Giulio Maria Pasinetti says moderate consumption is the key as excessive drinking carries a number of health risks, including alcohol dependence and liver damage.


The findings back up epidemiological research linking moderate alcohol consumption to a lower dementia risk, say the researchers.


For the research the team gave the mice, on a random basis, Cabernet Sauvignon or ethanol in their drinking water for seven months while another group of mice drank plain water.


All of the animals had a genetic defect that caused them to develop the type of damage that occurs in humans with Alzheimer’s disease.


The animals’ memories were then tested by putting them through a series of mazes, after the animals had been alcohol-free for three days.


The researchers found that the wine-drinking mice learned how to escape from the maze significantly faster than those drinking alcohol-spiked water or water only.


Pasinetti says that based on their findings and given that moderate wine consumption may protect the heart, older people in good health who don’t have the metabolic syndrome, high blood pressure, liver problems, issues with alcohol dependence or other reasons to avoid alcohol, can choose to drink red wine moderately as part of a healthy lifestyle.


The research will be presented on Oct 14-18 at the Society for Neuroscience annual meeting, in Atlanta and published in the FASEB Journal, November 2006.

WFP Food Provides Daily Meals To Mogadishu’s Hungry — First Time In 15 Years

Wednesday, July 29th, 2009

The United Nations Over the moon marvellous Food Design (WFP) and a
Somali
partner have started giving regular meals to tens of thousands of
desperately
hungry people in the seat of government Mogadishu — the agency’s primary ‘wet feeding’
in Somalia since the 1993 humanitarian emergency.

The meals started to be distributed on 25 November and numbers
are
expanding habitually. By Monday, WFP and its NGO partner SAACID were feeding
at
least 21,000 people in eight city districts. They plan to provide meals
in
up to 10 districts with a goal of up to 50,000 people each day.

“The intensity and scale of the crisis in Somalia is extremely alarming to
us
all - in some parts exquisite malnutrition levels surpass emergency
threshold
levels,” said WFP Somalia Country Chief Peter Goossens, adding that
the
outcome of the operation demonstrated the determination of WFP and
SAACID
to reach the voracious teeth of a multitude of obstacles.

“We set forth everyone to respect this vital humanitarian operation, which
is
feeding the desperately hungry”.

WFP was forced to start wet feeding in Mogadishu after terminal
shooting
incidents halted distributions of WFP dry rations in the ripping in
recent
June. As one-month rations of dried food are stored in beneficiaries’
homes, they are more liable to be looted than prepared meals eaten on
place.

Goossens said insecurity in Mogadishu was also causing the disruption
of
markets with consequent hyperinflation. There is a major be without
of
job, and a shortage of medical and sanitation
facilities.
Malnutrition rates in the capital are rising, with acute malnutrition
rates
sum total children under the period of 5 years estimated to be reaching 15
percent
or more.

With food assistance needs on the rise, WFP is appealing to donors
to
cross over a US$31 million funding gap. Mould week, WFP private sector
partner
YUM! Brands announced a US$1 million contribution from the funds
raised
during its ‘World Itch Relief Week’ rivalry in October. This is
the
largest corporate donation to WFP Somalia.

Some 30 kilometres west of Mogadishu, WFP is staunchly reaching
people
who fled heavy fighting in the capital. From matrix Saturday to Tuesday,
a
sole-month hand out of WFP food was distributed in the Afgoye area to
180,000
people — part of 600,000 people who fled their homes in the primary
this
year.

The top 10 donors to WFP’s two-year Protracted Relief and
Deliverance
Operation in Somalia ending in July 2008 are: the United States
(US$36
million), Canada (US$7.8 million), Netherlands (US$6.8 million),
Saudi
Arabia (US$3.3 million), Japan (US$3.2 million), Unified Nations
(US$2.5
million), multilateral funds (US$2.2 million — including US$1.9
million
from Sweden), Germany (US$2 million), Finland (US$1.9 million),
Ireland
(US$1.7 million).

WFP is the world’s largest humanitarian mechanism. Last year we gave food to
88 million people - mostly women and children - in 78 of the world’s
poorest countries.

WFP now provides RSS feeds to help journalists keep up with the
latest
hustle releases, videos and photos as they are published on wfp.org.
For
more details go through here.

WFP now has a dedicated ISDN speciality in Italy for attribute two-way
interviews
with WFP officials.

http://www.wfp.org

Ranbaxy Receives Tentative Approval From Us FDA To Market Risperidone Oral Solution

Tuesday, July 28th, 2009

Ranbaxy Laboratories Circumscribed (RLL) announced today that the Company has received apprehensive approval from the U.S. Food and Painkiller Administration (US FDA) to manufacture and market Risperidone Oral Solution, 1 mg/mL.

Risperdal® (risperidone) is indicated instead of the treatment of schizophrenia. Total annual market sales on account of risperidone voiced solution were $66 million (IMS - MAT: March 2006).

“We are pleased to receive this trial approval for Risperidone Enunciated Solution. This product represents a tomorrow chance for Ranbaxy and will be launched following final approval from the US FDA,” according to Jim Meehan, Vice President of Sales and Marketing quest of RPI, USA.

Ranbaxy Pharmaceuticals Inc. (RPI) based in Jacksonville, Florida, USA, is a wholly owned subsidiary of Ranbaxy Laboratories Reduced (RLL), India’s largest pharmaceutical institution. RPI is engaged in the sale and disposition of generic and branded prescription products in the U.S. healthcare system.

Ranbaxy Laboratories Limited, headquartered in India, is an integrated, enquire based, cosmopolitan pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy’s continued sharply defined unclear on R&D has resulted in a number of approvals in developed markets and significant progress in New Drug Discovery Delving. The Company’s foray into Blockbuster Drug Delivery Systems has led to proprietary “platform technologies”, resulting in a number of products under development. The Company is serving its customers in over 125 countries and has an expanding foreign portfolio of affiliates, joint ventures and alliances, rationale operations in 49 countries and manufacturing operations in 8 countries.

*Risperdal® is a registered trademark of Janssen Pharmaceutica Products, L.P.

http://www.ranbaxy.com

Better understanding of immune system activation

Sunday, July 26th, 2009

Linda Andersson at Malmo University in Sweden has studied the ability of dendritic cells to sample the adjacent surroundings. To conscious of how unique materials are entranced up and what happens within the cells can in spite of example facilitate the enlargement of new vaccines.

“The immune system is a large and important part of ourselves and the dendritic cells are important for the activation of this system”, Linda Andersson says.


“One task of the immune system is to protect the body from infections. The dendritic cells have an unique ability to obtain samples from its environment and treat the material, in process called endocytosis. In my study I have explored how dendritic cells recognise and capture particles.”


To study the endocytosing ability of dendritic cells Linda Andersson has used zeolite particles and through them different biomolecules are transported into the cell. With the help of zeolites you can follow different paths and study what happens within the cell.


“The result shows that zeolites are an useful tool for studying endocytosis and that there are differences between various dendritic cells”, Linda Andersson says.


“A method is developed for studying the early activities of the endocytosing mechanism within the cells. From this you can go further and study other processes and other types of cells.”


Zeolites belong to a group of silica particles which easily can adsorb different types of molecules, for example antibodies and other proteins. The type of molecule and the charge and amount of molecules affects the endocytosing ability of the cells.


Dendritic cells are found in different parts of the body, for example skin, mucous, spleen and circulating in the blood. Linda Andersson has chosen to study the cells in the blood. In her study dendritic cells from the blood are compared with dendritic cells produced in vitro, that is from a culture in an artificial environment. Dendritic cells are not so common in the blood. Through in vitro-culture you can easily produce many dendritic cells.


“The differences in the early events of the endocytosing mechanism between these two types of cells were considerable”, Linda Andersson says.


“This is important to point out, since in vitro-cells are among other things considered in the development of new vaccines. The blood cells are better at taking up particles while the in vitro-cells are better at taking up proteins and soluble molecules.”


The thesis by Linda Andersson contributes to an increased understanding of how the important dendritic cells work.


“I hope that the method developed in my study can be used to produce more knowledge about the different paths of the endocytosed material and how the dendritic cells recognise and capture the bodies own material and foreign harmful material”, Linda Andersson says.


http://www.vr.se

Why stopping smoking is hard

Sunday, July 26th, 2009

Just seeing someone smoke can trigger smokers to turn concluded their nascent efforts to drop-kick the way, according to creative inspect conducted at Duke University Medical Center.

Brain scans taken during normal smoking activity and 24 hours after quitting show there is a marked increase in a particular kind of brain activity when quitters see photographs of people smoking.


The study, which appears online in Psychopharmacology , sheds important light on why it’s so hard for people to quit smoking, and why they relapse so quickly, explains Joseph McClernon, an associate professor in the department of psychiatry and behavioral sciences at Duke University Medical Center.


“Only five percent of unaided quit attempts result in successful abstinence,” says McClernon. “Most smokers who try to quit return to smoking again. We are trying to understand how that process works in the brain, and this research brings us one step closer.”


The Duke researchers used a brain-imaging tool called functional MRI to visualize changes in brain activity that occurs when smokers quit. The smokers were scanned once before quitting and again 24 hours after they quit. Each time they were scanned while being shown photographs of people smoking.


“Quitting smoking dramatically increased brain activity in response to seeing the smoking cues,” says McClernon, “which seems to indicate that quitting smoking is actually sensitizing the brain to these smoking cues.”


Even more surprising, he adds, is the area of the brain that was activated by the cues. “We saw activation in the dorsal striatum, an area involved in learning habits or things we do by rote, like riding a bike or brushing our teeth. Our research shows us that when smokers encounter these cues after quitting, it activates the area of the brain responsible for automatic responses. That means quitting smoking may not be a matter of conscious control. So, if we’re really going to help people quit, this emphasizes the need to do more than tell people to resist temptation. We also have to help them break that habitual response.”


New treatment options at Duke are aiming to do just that. One area of research is focusing on the use of a nicotine patch prior to quitting smoking.


In previously published research, Jed Rose, Director of the Duke Center for Nicotine and Smoking Cessation Research and co-author of this paper as well, showed that wearing the patch and smoking a cigarette with no nicotine proved successful at breaking the learned behavior. “The smoking behavior is not reinforced because the act of smoking is not leading them to get the nicotine,” Rose said. “Doing this before people actually quit helps them break the habit so they start smoking less. We’re seeing people quit longer this way.”


http://www.dukemedicine.org/

Diagnosis Of Alzheimer’s Disease By Computer

Thursday, July 23rd, 2009

Computers are able to determine Alzheimer’s disease faster and more accurately than experts, according to research published in the journal Knowledge. The findings may workers ensure that patients are diagnosed earlier, increasing treatment options.

According to the Alzheimer’s Research Trust, there are over 700,000 people currently living in the UK with dementia, of which Alzheimer’s disease, a neurodegenerative disease, is the most common form.

Alzheimer’s is caused by the set up up in the brain of plaques and neurofibrillary tangles (tangles of brain tissue filaments), leading the mastermind to atrophy. Definitive diagnosis is usually no more than possible after death, but Alzheimer’s is usually diagnosed using a combination of brain scans, blood tests and interviews carried out by a trained clinician. The tests are time consuming, and distinguishing the disease from other forms of dementia can be demanding. The accuracy of diagnosis is solely respecting 85%

In the present climate, a team of researchers led by scientists at the Wellcome Trust Nucleus as far as something Neuroimaging at University College London, has shown that scans of patients with Alzheimer’s can be noble from those of healthy individuals and patients with other forms of dementia. Computers can identify the characteristic injure of Alzheimer’s disease with an Loosely precision as high as 96%.

“The advantage of using computers is that they prove cheaper, faster and more accurate than the current method of diagnosis,” explains Professor Richard Frackowiak from the Wellcome Positiveness Centre towards Neuroimaging. “The new method makes an objective diagnosis without the insufficiency for the sake human intervention. This wishes be solely winning for areas of the world where there is a shortage of trained clinicians and when a standardised conscientious diagnosis is needed, into example in panacea trials.”

The recent method, developed by Professor Frackowiak’s team, works by teaching a standard computer the differences between brain scans from patients with proven Alzheimer’s disease and people with no signs of the ailment at all. The two conditions can be distinguished with a high degree of correctness on a single clinical MRI scan. This could be especially of use for centres where facilities for extensive diagnostic workup are unavailable. A woman use might be to support the fearful elderly well with mild memory problems that they are not suffering from early Alzheimer’s.

The research tested scans from the US and the UK, from community and from hypothetical hospitals. The method was shown to be valid by testing it on scans from people who had their status proven by pathological survey - the gold norm. The results were uniformly encouraging. The computer could be taught the merit between normal and Alzheimer’s with one set of scans and then used to correctly “diagnose” scans from another become established. In all cases the results were better than the 86% correct diagnostic at all events of best clinical practice. The researchers also found they could individualize Alzheimer’s superior than clinicians from a nearly the same ailment called fronto-non-ecclesiastical dementia.

Professor Frackowiak emphasised that as symptoms from these diseases come on after a considerable amount of damage has already occurred in the brain, so it is signal to institute an meticulous diagnosis early to improve the chances of effectively preventing deterioration.

“The next footfall is to see whether we can use the mode to reliably track progression of the condition in a patient,” says Professor Frackowiak. “This could examine a powerful and non-invasive medium for screening the efficacy of new numb treatments speedily, without a need in spite of large costly clinical trials.”

—————————-
Article adapted by Medical Gossip Today from ingenious press release.
—————————-

Beginning: Craig Brierley

Wellcome Trust

Autism’s Origins: Mother’s Antibody Production May Affect Fetal Brain

Wednesday, July 22nd, 2009

The mothers of some autistic children may have made antibodies against their fetuses’ knowledge tissue during pregnancy that crossed the placenta and caused changes that led to autism, suggests inquiry led by Johns Hopkins Children’s Center investigators and published in the February issue of the Journal of Neuroimmunology.

The causes of autism, a disarray manifesting itself with a range of intellectual problems and marked by impaired social interactions, communication disorders and repetitive behaviors, continue unknown for an estimated 90 percent of children diagnosed with it. Genetic, metabolic and environmental factors have been implicated in diverse studies of autism, a disorder affecting 1 in 150 U.S. children, according to estimates by the Centers for Plague Control and Controlling.

“Now our research suggests that the mother’s immune system may be yet another middleman or a trigger in those already predisposed,” says lead investigator Harvey Balladeer, M.D., director of pediatric neurology at Hopkins Children’s.

Researchers caution that the findings needn’t be effect for the purpose alarm, but should be viewed instead as a step advance in untangling the complex nature of autism.

Mostly anecdotal past evidence of immune system involvement has emerged from unusual antibody levels in some autistic children and from postmortem brain tissue studies showing immune abnormalities in areas of the knowledge. Antibodies are proteins the body makes in response to viruses and bacteria or sometimes mistakenly against its own tissues. Yet, the womanhood of children with autism have no clinical evidence of autoimmune diseases, which prompted researchers to wonder whether the antibodies transferred from mother to young gentleman during pregnancy could interfere with the fetal brain directly.

To test their hypothesis, the research rig used a technique called immunoblotting (or Western blot technology), in which antibodies derived from blood samples are exposed to adult and fetal brain tissue to check whether the antibodies recognize and conduct oneself against specific brain proteins.

Comparing the antibody-mastermind interaction in samples obtained from 100 mothers of autistic children and 100 mothers of children without autism, researchers found either stronger reactivity or more areas of reactivity between antibodies and brain proteins in about 40 percent of the samples obtained from the mothers of autistic children. Favour, the company of devoted antibodies was associated with so-called developmental regression in children, increasingly immature behaviors that are a stamp of autism.

While the findings suggest an association between autism and the presence of fetal brains antibodies, the investigators say further studies are needed to ratify that particular antibodies do indeed cross the placenta and motive mutilation to the fetal brain.

“The nothing but incident that a pregnant woman has antibodies against the fetal brain doesn’t mean she will get an autistic child,” Singer says. “Autism is a complex circumstances and one that is likely caused by the interplay of immune, genetic and environmental factors.”

Researchers are also studying the effect of doting antibodies in pregnant mice. Prior results manifest that the offspring of mice injected with brain antibodies expose developmental and communal behaviors consistent with autism.

Postpositive major author on the study: Andrew W. Zimmerman, M.D., of the Center for Autism and Related Disorders at the Kennedy Krieger Pioneer.

Co-authors: Christina Morris and Colin Gause, both of Hopkins; Pam Gillin of the Kennedy Krieger Institute; and Stephen Crawford, Ph.D., Johns Hopkins Bloomberg Manner of Public Health. The mull over was funded by the Alliance for Autism Research.

Johns Hopkins Medicine
901 S. Agreement St., Ste 550
Baltimore, MD 21231
United States
http://www.hopkinsmedicine.org

Researchers develop DNA vaccine for West Nile virus

Wednesday, July 22nd, 2009

Researchers are developing a DNA-based vaccine against the dreaded West Nile virus (WNV), which can be transmitted from animals to humans. The unique participate of this vaccine is that it is also effective after onset of the plague, object of it has therapeutic properties.

SARS, avian flu, Ebola - outbreaks of deadly viral infections are becoming increasingly frequent. And we still don’t have vaccines for many of the pathogens responsible. One of the most dangerous classes of viral diseases is the zoonosis, which can be transmitted from animals to humans with sometimes fatal consequences. One of these is caused by the West Nile virus (WNV), which was first identified in Uganda in 1937. The virus was carried to the United States in 1999 and had spread through the whole of North America within five years. There is now a risk that it will propagate worldwide. Since its first appearance in the United States, around 400 people have died there after coming into contact with the West Nile virus. A new vaccine promises to provide protection.


Scientists at the Fraunhofer Institute for Cell Therapy and Immunology IZI in Leipzig have developed the DNA vaccine. “In this type of vaccine, DNA molecules known as plasmids extracted from the pathogen are used for inoculation, instead of the whole virus. They contain the genetic code for the antigens that stimulate the body to produce antibodies. We can thus replicate the virus’s natural infection route without actually triggering the disease,” explains Dr. Matthias Giese, the IZI’s head of vaccine development. Conventional methods of vaccination involve injecting a dead or weakened form of the pathogen into the patient’s body, which responds by producing the corresponding antibodies and developing immunity to the disease. An alternative is to inject a serum that already contains these antibodies. Such vaccines are merely preventive. By contrast with live vaccines, which carry a risk of provoking the disease, DNA vaccines are absolutely biologically safe. Moreover, they activate all existing defense mechanisms in the body, are cheap to produce and can be stored without a refrigerator - which makes them ideal for use in subtropical and tropical climates.


“Since the human immune system is very similar to that of other mammals, we are developing a cross-species vaccine for use in both veterinary and human medicine. And unlike conventional vaccines, DNA vaccines can be used both as prophylactics and as therapeutics, i.e. in cases where the disease is already present,” says Dr. Matthias Giese, citing the further benefits. The WNV vaccine has already passed initial tests. Giese expects the laboratory research to be completed by the end of 2009. After that, another 3 years or so will be needed for the approval procedure including clinical trials. Then, it is hoped, the world’s first therapeutic WNV vaccine will be ready for market.


http://www.fraunhofer.de/

Free full articles in medicine are hard to find, but we know where there are some. Impotencia masculina.

Fidel Castro Stable But Needs Time

Monday, July 20th, 2009

Cuban leader, Fidel Castro, who had a stomach operation to up a ’sharp intestinal crisis with sustained bleeding’, is quoted by state media as being ’stable’ although it will be many days before a verdict can be disposed. The 79-year-age-old president is said to be in ‘good spirits’, but details of his health are still secret. His fellow-clansman, Raul Castro, Cuba’s Plea Preacher, has taken over power briefly - the first interval this has happened during Castro’s 47 year rule.

A government source said responsibilities have been handed over to Raul Castro and six other leading Cuban officials - a arbitration made by a ‘completely conscious’ man.

Cuban state media, Granma, said Castro’s berth is ’stable, but heartfelt extension on health needs time.’ Information from the state media tends to be closely controlled and censured.

Reports from Cuba indicate that military and security personnel bring into the world stepped up their presence in some parts of the country - especially where road protests took place model year after a series of power cuts. Generally, though, most people are going relative to their business as routine. 70% of the country’s people were born after Castro took power.

In a memorandum quoted in the course state media Castro said the control was a serious one. Apparently, he went on to roughly that his well-being was stable, as were his spirits. He added that he could not make up uncontested hot item. The American forewarning means he cannot divulge any more poop close by his present state of health, state media quoted him as saying. Therefore his health is ‘a state secret’. He urged his people to oddments quieten and not to worry about capability US attacks as the motherland ‘is oven-ready for its defence.’

Rumours spread develop into Cuban exiles in Miami that Castro was dead. Ricardo Alarcon, the Cuban Parliament Spieler, said Castro is very much alive. Comprehend-well messages were sent from the leaders of Venezuela, Bolivia, Brazil, Mexico and China.

No one knows where the campaign took place and where he is currently being looked after.

Without detailed tidings it is straitening to speculate what caused his stomach bleeding and what his chances of a well-stacked recovery are. Gut bleeding could be caused by severe ulcers, cancer, diverticulosis or a number of other illnesses.

Fidel Castro’s Biography

1926 - August 13

Born in wealthy family’s sugar plantation in Oriente province, Cuba. Went to several scrupulous Catholic boarding schools.

1945

Studied law at Havana University. Completes and passes his definitely. An activist student who protests against a venal government.

1947

Joins Ortodoxos backer. The party’s aim is to bring on every side alter through peaceful and constitutional means.

1948

Takes part in a Pan-American conference in Bogota, Columbia. The congress develops into a riot where diverse people are killed. Castro’s happening make him wonder whether change may be richer reconsider achieved result of freedom warfare.

1949

Marries Mirta Diaz Balart. Son Fidelito (Little Fidel) is born. Splits up with strife five years later, keeps confinement of son.

1950

Sets up a private law practice in Havana, dedicated to portion the second to-informed on.

1952

Castro’s mentor, Edaurdo Chibas, kills himself during a radio program.

While Castro is planning his candidacy to the Bordello of Representatives General Batista organises a military coup and takes power. Castro tries to take evasion the new regime in court, but fails.

1953

Castro and some revolutionaries attack Moncada barracks on 26th July. Castro and Raul (brother) are caught and sentenced to 15 years in detention - Castro, in response to the charges made against him, says ‘History wish absolve me.’

1955

A general amnesty in Cuba, Castro and Raul are freed. Goes to Mexico where he sets up the ‘26th July Extremist Movement’. Meets Che Guevara, a doctor from Argentina.

1956

82 guerrillas carry out an deprecate in Oriente province, all but 12 die. Survivors seclusion to the hills and uphold faulty several French history Maquis attacks. The ensemble of 12 grows to 800. Castro’s movement grows as class reforms are promised as is the rout of Batista’s corrupt management.

1958

USA orders an arms embargo as support for Batista ceases. Batista attempts several offensive attacks, but slowly loses against the guerrilla attacks.

1959

Batista leaves the country. Castro and his men present Havana victoriously. Changed regime starts expropriating properties, angering US and foreign countries.

1960

Castro warms to USSR, signs pact to allow oil from the Russians. USA imposes economic blockade on Cuba, a blockade which still exists today.

1961

Diplomatic relations between Cuba and USA end. 1,300 Cuban exiles with CIA support try to invade at the Bay of Pigs - it is a humiliating defeat for the exiles.

1962

Cuban Missile Danger. President Kennedy accuses the Russians of placing long-index ballistic missiles in Cuba. US starts a naval blockade nearly Cuba. Precarious stand-high between USA and USSR. Kennedy tells Russians that any missiles from Cuba that are launched will result in a full meaning response from the USA.

Russians back down on October 24. Their ships turn round and go home and the missile sites in Cuba are taken down.

Castro becomes prevailing with the poor as he gives expropriated property to the masses. Previously foreign-owned companies are nationalised. Liberal health distress and tutelage arranged up for all citizens.

Castro becomes undesirable with the middle and loftier classes who try in their thousands to escape to the US. The country is a communist dictatorship.

1991

Soviet Harmoniousness communism collapses. No more Soviet money for Cuba. Cuba experiences a strict economic depression. Castro shifts to a certain and allows some types of private enterprises.

Castro then has 5 sons and lives with his customary-law chain, Dalia Soto del Valle (his partner suitable the last 30 years).

Castro is today the longest serving head of state in the times a deliver.

Written by: Christian Nordqvist
Rewrite man: Medical Account Today

Copyright: Medical News Today

Not to be reproduced without permission of Medical News Today

Concentrating On Different Aspects Of Pain Leads To Breakthrough In Migraine Genetics

Monday, July 20th, 2009

In a new study, published in the American Journal of Human Genetics, researchers were masterly for the initially on occasion to convincingly demonstrate a genomic locus to be linked to migraine susceptibility in two multiform populations.

Migraine is the most average cause of episodic difficulty, and by far the most common neurological justification of a doctor’s fall upon. It affects some 15% of the population, including some 41 million people in Europe, and places a largish burden on healthcare in both the developed and the developing world.

During the mould few years, great strides have been made in discovering joint genes influencing the susceptibility to average diseases, such as diabetes, Crohn’s affliction and schizophrenia. However, no genes have till been convincingly associated with migraine susceptibility, probably owed to the luxurious degree of variability of the affliction phenotype combined with the lack of viable laboratory tests.

“To accost this problem, we developed a new judgement approach concentrating on different symptoms of migraine”, says Professor Aarno Palotie (University of Helsinki, Finland, and the Sanger Introduce, Cambridge, UK). The new technique was used in the ample international study including 1700 migraine patients and their close relatives from 210 Finnish and Australian migraine families. The Finnish families had been ascertained thoroughly neurology clinics, while the Australian families had been collected through a twin study. An initial genome-wide microsatellite study was followed up by an independent targeted replication study.

Researchers identified one gene locus on chromosome 10q23, which showed important proof of genetic linkage in both populations wilful as well as in the replication study. The gene locus was especially strongly linked to female migraineurs. “In a further analysis, two independent prior studies, one Finnish and one Australian, had detected the same locus, but in those studies the level of evidence had been just subordinate to essence, and that reason the connection had so far been missed”, tells researcher Verneri Anttila from Palotie’s alliance.

This locus is thus linked to migraine in a total of 4000 migraineurs or their close relatives. “All of these findings depended on the newly discovered side of migraine genetics: different types of pain such as discomposure that pulsates or pain that is unilateral are more closely linked to specific genetic loci than community pain”, Palotie states.

In this study, researchers were able on the side of the gold medal time to convincingly demonstrate a genomic locus to be linked to migraine susceptibility in two varied populations. This is unusually interesting as Finland and Australia are genetically distant, and also as it tied together previous research, resulting in bare robust evidence for the treatment of pinpointing the susceptibility part.

“This deliberate over is the first international collaboration as excellently as the largest linkage investigation in migraine to date. It successfully applied renewed analysis strategies in detecting the locus and thus paved the way against following large combine studies”, Palotie and Anttila bid. According them, this study gives new hope to deciphering the migraine pathways and consequently discovering targets for future treatments, as well as discovering the fundamental migraine gene variants.

HELSINGIN YLIOPISTO (UNIVERSITY OF HELSINKI)
P.O. Box 33
FIN-00014 Helsinki
http://www.helsinki.fi